ID

28415

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Updated informed consent

Palabras clave

Versiones (3)
  1. 09/10/2017 09/10/2017 -
  2. 23/10/2017 23/10/2017 -
  3. 11/01/2018 11/01/2018 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

11 janvier 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Updated informed consent GSK study Chronic Coronary Heart Disease NCT00799903

Inglés

Updated informed consent GSK study Chronic Coronary Heart Disease NCT00799903

1 formularios  
Updated informed consent
Descripción

Updated informed consent

1. Subject study status at the time of review of updated Informed Consent
Descripción

(*if not able to contact please complete section below)

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348568
If subject currently on IP: Date updated safety text reviewed with subject
Descripción

Reminder: the deadline for updating subjects currently on IP is 3 months after the date of ethics approval

Tipo de datos

date

Alias
UMLS CUI [1]
C3174387
If subject currently on IP: Has the subject confirmed they are continuing on IP?
Descripción

If subject decides to permanently discontinue IP after review of the updated Informed Consent, complete the EOT/EW IP visit. For the IP Discontinuation reason, record the details in the 'Decision by subject or proxy' text box.l

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0805733
If subject currently on IP: Did the subject sign the updated Informed Consent form?
Descripción

If subject withdraws consent to participate in study after review of the updated Informed Consent, complete the EOS visit. For the Study Conclusion form Primary reason for withdrawal, record the details in the 'Withdrew Consent' text box. If pending [3]: Reminder - please update the eCRF to enter either "yes" or "no" after the subject attends their next clinic visit

Tipo de datos

text

Alias
UMLS CUI [1]
C0021430
If subject signed the updated Informed Consent form: date subject signed the updated Informed Consent form
Descripción

date subject signed the updated Informed Consent form

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0009797
If Subject who previously permanently stopped IP but remains in post-IP follow-up: Date subject informed of findings
Descripción

Date subject informed of findings

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0009797
Volver a la parte superior de la página

Similar models

Updated informed consent GSK study Chronic Coronary Heart Disease NCT00799903

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Updated informed consent
Item
1. Subject study status at the time of review of updated Informed Consent
integer
C2348568 (UMLS CUI [1])
Subject study status
Code List
1. Subject study status at the time of review of updated Informed Consent
CL Item
Subject currently on IP (23)
CL Item
Not applicable - subject no longer ongoing in study at time of reconsent (study withdrawal, lost to follow-up, died, *unable to contact subject in third party follow-up) (25)
CL Item
Subject who previously permanently stopped IP but remains in post-IP follow-up (including third party follow-up*) (24)
Date updated safety text reviewed with subject
Item
If subject currently on IP: Date updated safety text reviewed with subject
date
C3174387 (UMLS CUI [1])
continuation IP confirmation
Item
If subject currently on IP: Has the subject confirmed they are continuing on IP?
boolean
C0805733 (UMLS CUI [1])
Item
If subject currently on IP: Did the subject sign the updated Informed Consent form?
text
C0021430 (UMLS CUI [1])
updated Informed Consent form signature
Code List
If subject currently on IP: Did the subject sign the updated Informed Consent form?
CL Item
Pending - waiting for subject to visit the clinic to sign the form (3)
C0021430 (UMLS CUI-1)
C1611271 (UMLS CUI-2)
(Comment:en)
CL Item
Yes, date subject signed the updated Informed Consent form (Y)
C0021430 (UMLS CUI-1)
(Comment:en)
CL Item
No - subject confirmed that they will not sign. Subject must be withdrawn from IP if refuses to sign. Complete the EOT/EW IP visit. (N)
C0021430 (UMLS CUI-1)
(Comment:en)
date subject signed the updated Informed Consent form
Item
If subject signed the updated Informed Consent form: date subject signed the updated Informed Consent form
date
C0011008 (UMLS CUI [1,1])
C0009797 (UMLS CUI [1,2])
Date subject informed of findings
Item
If Subject who previously permanently stopped IP but remains in post-IP follow-up: Date subject informed of findings
date
C0011008 (UMLS CUI [1,1])
C0009797 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial